The immune system plays a critical role in maintaining physiological homeostasis and overall health.
When immune function is compromised, susceptibility to external pathogens increases, elevating the risk of viral and bacterial infections as well as disease development.
Enhancing immune function therefore involves strengthening weakened immune defense mechanisms affected by innate and environmental factors, ultimately reducing the risk of various illnesses.
ATG-V5 demonstrated immune-enhancing effects in a cyclophosphamide-induced immunosuppressed mouse model.
Treatment with ATG-V5 increased natural killer (NK) cell activity and restored thymus and spleen weights, indicating recovery of immune organ function.
ATG-V5 also enhanced humoral immunity by increasing immunoglobulin levels, including IgA, IgG, and IgM. In addition, cellular immune responses were promoted through increased expression of Th1, Th17, and Treg-related markers in the spleen, while key cytokines such as IFN-γ, IL-2, IL-6, and IL-10 were regulated toward normal physiological levels.